Drugs / ALLOB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04432389 | Jan 2021 → Jul 2022 | bone disorder | Bone Therapeutics S.A | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALLOB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04432389 ↗ |
| Modality | Cell therapy | “The study drug, ALLOB®, is constituted of bone cells produced from the bone marrow of healthy adult donors.” NCT04432389 ↗ |